Clinical trial examines drug combo as remission-inducing treatment options for LAM
Researchers at the University of Cincinnati (UC) begin a new clinical trial this fall, examining the potential role of a drug combination therapy to eliminate lymphangioleiomyomatosis (LAM) cells. The trial will look at the ...
Aug 7, 2017
0
854